Abstract
Activation of transcription factor NF-κB in the innate immune system is tightly regulated to prevent excessive inflammatory responses. How NF-κB activation is terminated, however, is not fully understood. Here we report that PDLIM2 negatively regulated NF-κB activity, acting as a nuclear ubiquitin E3 ligase targeting the p65 subunit of NF-κB. PDLIM2 bound to p65 and promoted p65 polyubiquitination. In addition, PDLIM2 targeted p65 to discrete intranuclear compartments where polyubiquitinated p65 was degraded by the proteasome. PDLIM2 deficiency resulted in larger amounts of nuclear p65, defective p65 ubiquitination and augmented production of proinflammatory cytokines in response to innate stimuli. Our findings delineate a pathway by which PDLIM2 terminates NF-κB activation through intranuclear sequestration and subsequent degradation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Medzhitov, R. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1, 135–145 (2001).
Hayden, M.S. & Ghosh, S. Signaling to NF-κB. Genes Dev. 18, 2195–2224 (2004).
Yamamoto, Y. & Gaynor, R.B. Role of NF-κB pathway in the pathogenesis of human diseases states. Curr. Mol. Med. 1, 287–296 (2001).
Tak, P.P. & Firestaein, G.S. NF-κB: a key role in inflammatory diseases. J. Clin. Invest. 107, 7–11 (2001).
Arenzana-Seisdedos, F. et al. Inducible nuclear expression of newly synthesized IκBα negatively regulates DNA-binding and transcriptional activities of NF-κB. Mol. Cell. Biol. 15, 2689–2696 (1995).
Arenzana-Seisdedos, F. et al. Nuclear localization of IκBα promotes active transport of NF-κB from the nucleus to the cytoplasm. J. Cell Sci. 110, 369–378 (1997).
Ghosh, S. & Karin, M. Missing pieces in the NF-κB puzzle. Cell, 109, S81–S96 (2001).
Saccani, S., Marazzi, I., Beg, A.A. & Natoli, G. Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor κB response. J. Exp. Med. 200, 107–113 (2004).
Muratani, M. & Tansey, W.P. How the ubiquitin-proteasome system controls transcription. Nat. Rev. Mol. Cell Biol. 4, 192–201 (2003).
Dornan, D. et al. The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 429, 86–92 (2004).
Wertz, I.E. et al. Human de-etiolated-1 regulates c-Jun by assembling a CUL4A ubiquitin ligase. Science 303, 1371–1374 (2004).
Ryo, A. et al. Regulation of NF-κB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol. Cell 12, 1413–1426 (2003).
Lawrence, T., Bebien, M., Liu, G.Y., Nizet, V. & Karin, M. Ikkα limits macrophage NF-κB activation and contributes to the resolution of inflammation. Nature 434, 1138–1143 (2005).
Torrado, M., Senatorov, V.V., Trivedi, R., Fariss, R.N. & Tomarev, S.I. Pdlim2, a novel PDZ-LIM domain protein, interacts with α-actinins and filamin A. Invest. Ophthalmol. Vis. Sci. 45, 3955–3963 (2004).
Tanaka, T., Soriano, M.A. & Grusby, M.J. SLIM is a nuclear ubiquitin E3 ligase that negatively regulates STAT signaling. Immunity 22, 729–736 (2005).
Loughran, G. et al. Mystique is a new insulin-like growth factor-I-regulated PDZ-LIM domain protein that promotes cell attachment and migration and suppresses anchorage-independent growth. Mol. Biol. Cell 16, 1811–1822 (2005).
Kadrmas, J.K. & Beckerle, M.C. The LIM domain: From the cytoskelton to the nucleus. Nat. Mol. Cell Biol. 5, 920–931 (2004).
Anton, L.C. et al. Intracellular localization of proteasomal degradation of a viral antigen. J. Cell Biol. 146, 113–124 (1999).
Rockel, T.D., Stuhlmann, D. & von Mikecz, A. Proteasomes degrade proteins in focal subdomains of the human cell nucleus. J. Cell Sci. 118, 5231–5242 (2005).
von Mikecz, A. The nuclear ubiquitin-proteasome system. J. Cell Sci. 119, 1977–1984 (2006).
Capili, A.D., Schultz, D.C., Rauscher, F.J., III & Borden, K.L.B. Solution structure of the PHD domain from the KAP-1 corepressor: structural determinants for PHD, RING and LIM zinc-binding domains. EMBO J. 20, 165–177 (2001).
Tam, W.F., Lee, L.H., Davis, L. & Sen, R. Cytoplasmic sequestration of rel proteins by IκBα requires CRM1-dependent nuclear export. Mol. Cell. Biol. 20, 2269–2284 (2000).
Zhong, S., Salomoni, P. & Pandolfi, P.P. The transcriptional role of PML and the nuclear body. Nat. Cell Biol. 2, E85–E90 (2000).
Zimber, A., Nguyen, Q.D. & Gespach, C. Nuclear bodies and compartments: functional roles and cellular signalling in health and disease. Cell. Signal. 16, 1085–1104 (2004).
Ouaaz, F., Li, M. & Beg, A.A. A critical role for the RelA subunit of nuclear factor kB in regulation of multiple immune-response genes and in Fas-induced cell death. J. Exp. Med. 189, 999–1004 (1999).
Conaway, R.C., Brower, C.S. & Conaway, J.W. Emerging roles of ubiquitin in transcription regulation. Science 296, 1254–1258 (2002).
Floyd, Z.E., Trausch-Azar, J.S., Reinstein, E., Ciechanover, A. & Schwartz, A.L. The nuclear ubiquitin-proteasome system degrades MyoD. J. Biol. Chem. 276, 22468–22475 (2001).
Shirangi, T.R., Zaika, A. & Moll, U.M. Nuclear degradation of p53 occurs during down-regulation of the p53 response after DNA damage. FASEB J. 16, 420–422 (2002).
Matera, A.G. Nuclear bodies: multifaced subdomains of the interchromatin space. Trends Cell Biol. 9, 302–309 (1999).
Johnston, J.A., Ward, C.L. & Kopito, R.R. Aggresomes: a cellular response to misfolded proteins. J. Cell Biol. 143, 1883–1898 (1998).
Goldberg, A.L. Protein degradation and protection against misfolded or damaged proteins. Nature 426, 895–899 (2003).
Fabunmi, R.P., Wigley, W.C., Thomas, P.J. & DeMartino, G.N. Interferon γ regulates accumulation of the proteasome activator PA28 and immunoproteasomes at nuclear PML bodies. J. Cell Sci. 114, 29–36 (2000).
Sachdev et al. PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes Dev. 15, 3088–3103 (2001).
Ross, S., Best, J.L., Zon, L.I. & Gill, G. SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization. Mol. Cell 10, 831–842 (2002).
Harris, B.Z. & Lim, W.A. Mechanism and role of PDZ domains in signaling complex assembry. J. Cell Sci. 114, 3219–3231 (2001).
Schulz, T.W. et al. Actin/α-actinin-dependent transport of AMPA receptors in dendritic spines: role of the PDZ-LIM protein RIL. J. Neurosci. 24, 8584–8589 (2004).
Bettinger, B.T., Gilbert, D.M. & Amberg, D.C. Actin up in the nucleus. Nat. Mol. Cell. Biol. 5, 410–415 (2004).
Gettemans, J. et al. Nuclear actin-binding proteins as modulators of gene transcription. Traffic 6, 847–857 (2005).
Nemeth, Z.H. et al. Disruption of the cytoskeleton results in nuclear factor-κB activation and inflammatory mediator production in cultured human intestinal epithelial cells. J. Cell. Physiol. 200, 71–81 (2004).
Wu, W.S. et al. Promyelocytic leukemia protein sensitizes tumor necrosis factor alpha-induced apoptosis by inhibiting the NF-κB survival pathway. J. Biol. Chem. 278, 12294–12304 (2003).
Birbach, A. et al. Signaling molecules of the NF-κB pathway shuttle constitutively between cytoplasm and nucleus. J. Biol. Chem. 277, 10842–10851 (2002).
Fu, L. et al. Nuclear aggresomes form by fusion of PML-associated aggregates. Mol. Biol. Cell 16, 4905–4917 (2005).
von Mikecz, A. Xenobiotic-induced autoimmunity and protein aggregation diseases share a common subnuclear pathology. Autoimmun. Rev. 4, 214–218 (2005).
Chen, M. et al. Recruitment of topoisomerase I (Scl-70) to nucleoplasmic proteasomes in response to xenobiotics suggests a role for altered antigen processing in scleroderma. Arthritis Rheum. 52, 877–884 (2005).
Campanero, M.R. & Flemington, E.K. Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumor suppressor protein. Proc. Natl. Acad. Sci. U.S.A. 94, 2221–2226 (1997).
Fey, E.G., Wan, K.M. & Penman, S. Epithelial cytoskeletal framework and nuclear matrix-intermediate filament scaffold: Three-dimensional organiztion and protein composition. J. Cell Biol. 98, 1973–1984 (1984).
Acknowledgements
We thank K. Hoshino, T. Sugiyama, M. Saito for discussions; N. Okita, N. Iwami, Y. Fukuda and E. Haga for technical assistance; S. Haraguchi for secretarial assistance; A. Furuno for help with confocal microscopy; and R. Triendl, L. Leclercq and P. Burrows for critical review of the manuscript. The plasmid pCII-CMV-MCS-IRES-Venus was provided by H. Miyoshi (University of Tsukuba) and A. Miyawaki (RIKEN Brain Science Institute), and the ELAM-1 luciferase reporter construct was provided by D. Golenbock (University of Massachusetts Medical School). Supported by Scientific Research of MEXT (Ministry of Education, Culture, Sports. Science and Technology) and the Japan Society for the Promotion of Science (T.T. and T.K.), the Mochida Memorial Foundation for Medical and Pharmaceutical Research (T.T. and T.K.), the RIKEN Strategic Research Program (T.T. and T.K.), the Uehara Memorial Foundation (T.K.), the Sumitomo Foundation (T.T.), the National Institutes of Health (AI506296 to M.J.G.) and the G. Harold and Leila Y. Mathers Charitable Foundation (M.J.G.).
Author information
Authors and Affiliations
Contributions
T.T. contributed to general experiments and design with the direction and supervision of T.K.; M.J.G. contributed to discussions and manuscript criticism.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Fig. 1
Interaction of PDLIM2 mutants lacking LIM or PDZ domains with endogenous p65 is comparable to that of wild-type PDLIM2. (PDF 67 kb)
Supplementary Fig. 2
PDZ domain of PDLIM2 is not required for p65 ubiquitination. (PDF 47 kb)
Supplementary Fig. 3
Enhanced proinflammatory cytokine production in Pdlim2−/− cells in the absence of IFN-γ. (PDF 41 kb)
Rights and permissions
About this article
Cite this article
Tanaka, T., Grusby, M. & Kaisho, T. PDLIM2-mediated termination of transcription factor NF-κB activation by intranuclear sequestration and degradation of the p65 subunit. Nat Immunol 8, 584–591 (2007). https://doi.org/10.1038/ni1464
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni1464
This article is cited by
-
ABLIM1, a novel ubiquitin E3 ligase, promotes growth and metastasis of colorectal cancer through targeting IĸBα ubiquitination and activating NF-ĸB signaling
Cell Death & Differentiation (2024)
-
Tsc2 mutation rather than Tsc1 mutation dominantly causes a social deficit in a mouse model of tuberous sclerosis complex
Human Genomics (2023)
-
N-acetyltransferase 10 promotes cutaneous wound repair via the NF-κB-IL-6 axis
Cell Death Discovery (2023)
-
Early innate immune response triggered by the human respiratory syncytial virus and its regulation by ubiquitination/deubiquitination processes
Journal of Biomedical Science (2022)
-
Osteocytes directly regulate osteolysis via MYD88 signaling in bacterial bone infection
Nature Communications (2022)